|
|
|
|
|
|
|
|
|
|
|
23.06.25 - 14:06
|
Pharma & Vaccine Industry Leader Eddie Gray joins Botanical Solution Inc. (BSI) Board of Directors (Business Wire)
|
|
|
Former GlaxoSmithKline President (Europe), Dynavax CEO & UK Government Chair Covid-19 Taskforce to provide strategic guidance for Botanical Solution's future developmentDAVIS, Calif.--(BUSINESS WIRE)--Eddie Gray, veteran pharmaceutical and vaccine industry executive, has joined the Board of Directors of Botanical Solution Inc. (BSI). Mr. Gray is the former President of GlaxoSmithKline Europe, former CEO Dynavax Technologies Corp. and former Chair of the UK Government's Covid-19 Antivirals Task Force. Eddie earned his B.Sc. (Honors) in Chemistry and Management Studies from the University of London, and completed his MBA at the Cranfield School of Management, England.
Botanical Solution produces the Gold Standard vaccine adjuvant QS-21. Currently, QS-21 is a vital component in FDA-approved vaccines against Shingles, Respiratory Syncytial Virus (RSV), Covid-19 and Malaria. QS-21 is at present extracted from an exotic tree, the Quillaja saponaria, which grows in the country of Chile. Chilean deforestation l...
|
|
|
22.06.25 - 19:39
|
AppLovin, First Solar And Li Auto Are Among Top 10 Large Cap Losers Last Week (June 16-20): Are The Others In Your Portfolio? (Benzinga)
|
|
|
Top 10 worst performing large-cap stocks last week: APP, FSLR, JHX, ONC, GSK, ACN, ANET, LI, CPAY, MA. Reasons include short-sell report, tax bill, and market selloff.
read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.06.25 - 15:36
|
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US (Business Wire)
|
|
|
Grant funding will be provided to support national, state, and local non-profit organizations and community-based groups focused on lupus
New resources and tools will support implementation of community-led programs designed to improve earlier diagnosis, enhance awareness of and access to evidence-based treatment, and/or advance communication between patients and providers
Deadline for proposals is September 1, 2025
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and lupus nephritis (LN).
“Too many people living with lupus face delays in diagnosis and disconnects in care,” said Court Horncastle, Senior Vice President at GSK. “With this initiative, we're proud to support the organizations working within local communities to improve diagnosis, access to optimal care, and connection for those impacted by lupus.”
GSK is seek...
|
|
|
16.06.25 - 14:33
|
Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes (GlobeNewswire EN)
|
|
|
CHICAGO and FORT WORTH, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced today that the Company will be added to the Russell 3000® Index, with automatic inclusion in the Russell 2000® Index, effective after the U.S. market close on June 27, as part of the 2025 Russell indexes annual reconstitution. The inclusion follows the initial announcement on Friday, May 23, and the latest update on Friday, June 13, 2025, in connection with the annual reconstitution of the Russell U.S. Indexes....
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
